Electropharmacology of potassium canrenoate.
D000200:Action Potentials / Q000187:drug effects; D000737:Androstenols / Q000494:pharmacology*; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D004347:Drug Interactions; D006168:Guinea Pigs; D006329:Heart Conduction System / Q000187:drug effects*; D006352:Heart Ventricles / Q000294:innervation; D066298:In Vitro Techniques; D007664:Ketosteroids / Q000494:pharmacology; D008297:Male; D010042:Ouabain / Q000037:antagonists & inhibitors / Q000494:pharmacology; D011422:Propionates / Q000494:pharmacology
D000737:Androstenols; D000889:Anti-Arrhythmia Agents; D007664:Ketosteroids; D011422:Propionates; D010042:Ouabain